LAUSR

The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests

Sign Up to like & get
recommendations!
1 Published in 2022 at "Stem Cells Translational Medicine"

DOI: 10.1093/stcltm/szac036

Abstract: Abstract Pluripotent stem cell (PSC)-based cell therapies have increased steadily over the past few years, and assessing the risk of tumor formation is a high priority for clinical studies. Current in vivo tumorigenesis studies require… read more here.

Keywords: eye chamber; chamber; vivo; tumorigenesis ... See more keywords